Literature DB >> 8589304

Effect of chronic experimental renal insufficiency on urate metabolism.

N D Vaziri1, R W Freel, M Hatch.   

Abstract

The rise in plasma uric acid (UA) in chronic renal failure (CRF) is quite limited. This may be due to either increased extrarenal excretion, diminished biosynthesis, and/or enhanced degradation of uric acid. The intestinal flux studies revealed a striking modification of urate transport from no net flux to a net secretory flux in the jejunum and from a basal net absorptive to a net secretory flux in the colon of CRF animals. In addition, CRF animals showed a marked reduction in hepatic, renal, and enteric tissue xanthine oxidase activity and no significant change in tissue uricase activity. The correction of anemia with erythropoietin did not significantly alter the plasma concentration or urinary excretion of urate. Thus, enhanced enteric excretion and depressed production of uric acid (reduced xanthine oxidase activity) may account for the lack of significant hyperuricemia in CRF.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8589304     DOI: 10.1681/ASN.V641313

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  27 in total

1.  Effect of Synbiotic Therapy on Gut-Derived Uremic Toxins and the Intestinal Microbiome in Patients with CKD.

Authors:  Nosratola D Vaziri
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-15       Impact factor: 8.237

Review 2.  Hyperuricemia and Hypertension: Links and Risks.

Authors:  Douglas J Stewart; Valerie Langlois; Damien Noone
Journal:  Integr Blood Press Control       Date:  2019-12-24

3.  Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxins.

Authors:  Sunny Eloot; Eva Schepers; Daniela V Barreto; Fellype C Barreto; Sophie Liabeuf; Wim Van Biesen; Francis Verbeke; Griet Glorieux; Gabriel Choukroun; Ziad Massy; Raymond Vanholder
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-26       Impact factor: 8.237

Review 4.  Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.

Authors:  Alice Sabatino; Giuseppe Regolisti; Carmela Cosola; Loreto Gesualdo; Enrico Fiaccadori
Journal:  Curr Diab Rep       Date:  2017-03       Impact factor: 4.810

Review 5.  Uric acid as a target of therapy in CKD.

Authors:  Diana I Jalal; Michel Chonchol; Wei Chen; Giovanni Targher
Journal:  Am J Kidney Dis       Date:  2012-10-09       Impact factor: 8.860

6.  Serum metabolites are associated with all-cause mortality in chronic kidney disease.

Authors:  Jiun-Ruey Hu; Josef Coresh; Lesley A Inker; Andrew S Levey; Zihe Zheng; Casey M Rebholz; Adrienne Tin; Lawrence J Appel; Jingsha Chen; Mark J Sarnak; Morgan E Grams
Journal:  Kidney Int       Date:  2018-06-02       Impact factor: 10.612

7.  CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity.

Authors:  Nosratola D Vaziri
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-11       Impact factor: 2.894

8.  Uric acid transporter ABCG2 is increased in the intestine of the 5/6 nephrectomy rat model of chronic kidney disease.

Authors:  Hirofumi Yano; Yoshifuru Tamura; Kana Kobayashi; Masayuki Tanemoto; Shunya Uchida
Journal:  Clin Exp Nephrol       Date:  2013-04-13       Impact factor: 2.801

9.  Effects of uric acid dysregulation on the kidney.

Authors:  Lashodya V Dissanayake; Denisha R Spires; Oleg Palygin; Alexander Staruschenko
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-30

10.  Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis.

Authors:  Dimitrios Daoussis; Vasileios Panoulas; Tracey Toms; Holly John; Ioannis Antonopoulos; Peter Nightingale; Karen M J Douglas; Rainer Klocke; George D Kitas
Journal:  Arthritis Res Ther       Date:  2009-07-24       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.